@shraddhaha Interesting!
Two hurdles openstreet map will block once high usage so better go with google api for this as well
Scrapping data is dependency and high volumes may again trigger the source companies
I sent one of my friends a huge message about a sample Iโm sending her for trial, and she was on vacation. She sent me a voice note saying, โBaby Iโll read this asap, Iโm just out with a bunch of people. Iโm your biggest supporter, donโt ever feel otherwise, Iโm not ignoring your message.โ
It really is that simple to be a good friend. To reassure people. To show up. To make the people you love feel seen and supported.
as someone who worked in pharma consulting, let me tell you: the big winners of the GLP-1 race in india are those manufacturing the pens, cartridges & dose selector pens used to inject GLP-1s
pharma companies (glenmark, sun pharma, dr reddy's etc) selling semaglutide are currently fighting a race to the bottom, price wise
but all these companies selling semaglutide will need prefilled injectable pen syringes to get the semaglutide molecule into patients
people generally prefer GLP-1s in pen form over vial form because that means that you don't have to go a doc every week